Clinical trial

Selegiline to Zelapar Switch Study in Parkinson Disease Patients

NCT00640159

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-01-01

PhasePHASE4

Study timeline

Study start (unknown)2007-01-01Date precision: month

Registry last updated2023-08-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

ZelaparDRUG · verified · RxNorm: Zelapar

Sponsors & collaborators

Baylor College of Medicinelead sponsor

Mapped research locations

HoustonTexas, United States1 DallasTexas, United States1 La JollaCalifornia, United States1 Boca RatonFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00640159 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.